FSLLRY-NH2
Cat.No:CLP1108 Solarbio
CAS:245329-02-6
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:245329-02-6
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 245329-02-6 |
Sequence(1LC) | FSLLRY-NH2 |
Sequence(3LC) | Phe-Ser-Leu-Leu-Arg-Tyr-NH2 |
Molecular Formula | C39H60N10O8 |
Molecular Weight | 796.97 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Solubility | DMSO:100 mg/mL; *Ultrasonic solubilization; |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Substrate and Enzyme Inhibitors |
Background | PAR-2 antagonist. FSLLRY-amide inhibited activation of PAR-2 by trypsin in PAR-2 receptor expressing KNRK cells. Half-maximal inhibition of calcium signaling was observed at about 50 μM. In contrast, the activation of PAR-2 by SLIGRL-amide was not inhibited by FSLLRY-amide. |
In Vitro | undetected |
In Vivo | Treatment with FSLLRY-NH2 (50 μg per rat administered intranasally at 1 hour postresuscitation) significantly improves neurological outcome and reduces the number of degenerating hippocampal neurons after ACA (asphyxial CA). |
Reference | [1] B.Al-Ani et al., J. Pharmacol. Exp. Ther., 300, 702 (2002); [2] S.Wilson et al., Biochem. J., 388, 967 (2005). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.